Pages that link to "Q44617982"

The following pages link to Comparison of estrogen receptor and epidermal growth factor receptor content of primary and involved nodes in human breast cancer (Q44617982):

Displaying 13 items.

• Juvenile gigantomastia: report of a case (Q28267785) (← links)
• The epidermal growth factor receptor in breast cancer. (Q33959323) (← links)
• Variability in hormone and growth factor receptor expression in primary versus recurrent, metastatic, and post-neoadjuvant breast carcinoma (Q38000948) (← links)
• The in vitro and in vivo anti‐tumor effect of KO‐202125, a sauristolactam derivative, as a novel epidermal growth factor receptor inhibitor in human breast cancer (Q39612495) (← links)
• Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases. (Q43254569) (← links)
• Comparative study of the expression of metalloproteases and their inhibitors in different localizations within primary tumours and in metastatic lymph nodes of breast cancer (Q44131334) (← links)
• Clinical significance of tumor content of epidermal growth factor receptor in breast cancer (Q44638446) (← links)
• Genetic alterations in primary breast cancers and their metastases: direct comparison using modified comparative genomic hybridization (Q46564449) (← links)
• Should liver metastases of breast cancer be biopsied to improve treatment choice? (Q51054351) (← links)
• Hormone receptors and HER-2 changes during breast cancer progression: clinical implications (Q54561632) (← links)
• High positive rate of pS2 expression in forefront intraductal cancerous area in breast cancer. (Q55515027) (← links)
• Immunohistochemical study of estrogen receptors in primary breast carcinomas and their lymph node metastases including comparison of two monoclonal antibodies (Q72108727) (← links)
• Epidermal growth factor receptor in breast cancer: correlation of quantitative immunocytochemical assays to prognostic factors (Q72919556) (← links)